首页> 美国卫生研究院文献>Cell Regulation >Double minute chromosomes carrying the human multidrug resistance 1 and 2 genes are generated from the dimerization of submicroscopic circular DNAs in colchicine-selected KB carcinoma cells.
【2h】

Double minute chromosomes carrying the human multidrug resistance 1 and 2 genes are generated from the dimerization of submicroscopic circular DNAs in colchicine-selected KB carcinoma cells.

机译:秋水仙素选择的KB癌细胞中亚显微环状DNA的二聚化产生了带有人类多药耐药性1和2基因的微小染色体。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

This study characterizes amplified structures carrying the human multidrug resistance (MDR) genes in colchicine-selected multidrug resistant KB cell lines and strongly supports a model of gene amplification in which small circular extrachromosomal DNA elements generated from contiguous chromosomal DNA regions multimerize to form cytologically detectable double minute chromosomes (DMs). The human MDR1 gene encodes the 170-kDa P-glycoprotein, which is a plasma membrane pump for many structurally unrelated chemotherapeutic drugs. MDR1 and its homolog, MDR2, undergo amplification when KB cells are subjected to stepwise selection in increasing concentrations of colchicine. The structure of the amplification unit at each step of drug selection was characterized using both high-voltage gel electrophoresis and pulsed-field gel electrophoresis (PFGE) techniques. An 890-kb submicroscopic extrachromosomal circular DNA element carrying the MDR1 and MDR2 genes was detected in cell line KB-ChR-8-5-11, the earliest step in drug selection in which conventional Southern/hybridization analyses detected MDR gene amplification. When KB-ChR-8-5-11 was subjected to stepwise increases in colchicine, this circular DNA element dimerized as detected by PFGE with and without digestion with Not 1, which linearizes the 890-kb amplicon. This dimerization process, which also occurred at the next step of colchicine selection, resulted in the formation of cytologically detectable DMs revealed by analysis of Giemsa-stained metaphase spreads.
机译:这项研究表征了在秋水仙碱选择的多药耐药性KB细胞系中携带人多药耐药性(MDR)基因的扩增结构,并强烈支持一种基因扩增模型,在该模型中,从连续染色体DNA区域产生的小环状染色体外DNA元素聚合形成细胞学上可检测的双链微小染色体(DM)。人类MDR1基因编码170-kDa P-糖蛋白,它是许多结构上不相关的化疗药物的质膜泵。当KB细胞在逐渐增加浓度的秋水仙碱中进行逐步选择时,MDR1及其同源物MDR2进行扩增。使用高压凝胶电泳和脉冲场凝胶电泳(PFGE)技术对药物选择每个步骤中扩增单元的结构进行了表征。在细胞系KB-ChR-8-5-11中检测到一个带有MDR1和MDR2基因的890kb亚显微染色体外环状DNA元件,这是药物选择的最早步骤,其中常规的Southern /杂交分析检测到MDR基因的扩增。当KB-ChR-8-5-11的秋水仙碱含量逐步增加时,该环状DNA元件通过PFGE(用和不用Not 1消化)检测而二聚化,从而线性化了890kb扩增子。这种二聚化过程(也发生在秋水仙碱选择的下一步骤中)导致通过吉姆萨染色的中期扩散分析揭示了细胞学上可检测的DM。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号